|
81 |
Multiple sclerosis therapy consensus group (MSTCG): answers to the discussion questions
Enthalten in Neurological research and practice Bd. 3, 6.8.2021, Nr. 1, date:12.2021: 1-7
|
|
|
|
82 |
Multiple Sklerose Therapie Konsensus Gruppe (MSTKG): Positionspapier zur verlaufsmodifizierenden Therapie der Multiplen Sklerose 2021 (White Paper)
Enthalten in Der Nervenarzt Bd. 92, 23.7.2021, Nr. 8, date:8.2021: 773-801
|
|
|
|
83 |
Network alterations underlying anxiety symptoms in early multiple sclerosis
Enthalten in Journal of neuroinflammation Bd. 19, 24.5.2022, Nr. 1, date:12.2022: 1-13
|
|
|
|
84 |
Preventing disease progression in multiple sclerosis—insights from large real-world cohorts
Enthalten in Genome medicine Bd. 14, 20.4.2022, Nr. 1, date:12.2022: 1-3
|
|
|
|
85 |
Publisher Correction: Maladaptive cortical hyperactivity upon recovery from experimental autoimmune encephalomyelitis
Enthalten in Nature neuroscience Bd. 22, 7.11.2018, Nr. 1, date:1.2019: 144
|
|
|
|
86 |
Spatial transcriptomics and neurofilament light chain reveal changes in lesion patterns in murine autoimmune neuroinflammation
Enthalten in Journal of neuroinflammation Bd. 20, 13.11.2023, Nr. 1, date:12.2023: 1-17
|
|
|
|
87 |
The frequency of follicular T helper cells differs in acute and chronic neuroinflammation
Enthalten in Scientific reports Bd. 10, 24.11.2020, Nr. 1, date:12.2020: 1-11
|
|
Administration
